---
figid: PMC6721565__cancers-11-01162-g003
figlink: /pmc/articles/PMC6721565/figure/cancers-11-01162-f003/
number: Figure 3
caption: LRP6 and WNT/β-catenin pathway alterations in epithelial cancers. (A) In
  colorectal cancer (CRC), LRP6 overexpression is observed in 61% of malignant tissues
  isolated from patients. (i) Mutations in the E3 ubiquitin-protein ligase RNF43,
  (ii) downregulation of the antagonist DKK1 and (iii) overactivation of the RAS/MAPK
  pathway result in the recruitment of degradation complex components at the membrane
  and WNT/β-catenin pathway overactivation. (B) In hepatocellular carcinomas (HCCs),
  LRP6 is overexpressed in 45%–75% of HCC tumours. Downregulation of miR-126-3p, miR-202
  and single-nucleotide polymorphism of miR-1269 result in increased LRP6 mRNA stability
  and protein levels. The long non-coding RNA FOX2-ASI, upregulated in HCC, targets
  and downregulates DKK1 mRNA (LRP6 inhibitor), thus increasing LRP6 membrane levels.
  (C) In breast cancers (BCs), LRP6 overexpression is observed in 20%–36% of carcinomas,
  and β-catenin nuclear accumulation is reported in 40%–60% of cases. (D) In pancreatic
  ductal adenocarcinoma (PDAC), (i) mutations of RNF43 are observed in 5%–10% of PDAC
  patients, (ii) down-regulation of miR-454 and (iii) upregulation of LINC01133—a
  long non-coding RNA which induces DKK1 promoter methylation (decreasing DKK1 expression)—all
  explain increased LRP6 expression and subsequent increased β-catenin-dependent signaling.
pmcid: PMC6721565
papertitle: A Role for the WNT Co-Receptor LRP6 in Pathogenesis and Therapy of Epithelial
  Cancers.
reftext: Jennifer Raisch, et al. Cancers (Basel). 2019 Aug;11(8):1162.
pmc_ranked_result_index: '40993'
pathway_score: 0.9662753
filename: cancers-11-01162-g003.jpg
figtitle: LRP6 and WNT/Beta-catenin pathway alterations in epithelial cancers
year: '2019'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6721565__cancers-11-01162-g003.html
  '@type': Dataset
  description: LRP6 and WNT/β-catenin pathway alterations in epithelial cancers. (A)
    In colorectal cancer (CRC), LRP6 overexpression is observed in 61% of malignant
    tissues isolated from patients. (i) Mutations in the E3 ubiquitin-protein ligase
    RNF43, (ii) downregulation of the antagonist DKK1 and (iii) overactivation of
    the RAS/MAPK pathway result in the recruitment of degradation complex components
    at the membrane and WNT/β-catenin pathway overactivation. (B) In hepatocellular
    carcinomas (HCCs), LRP6 is overexpressed in 45%–75% of HCC tumours. Downregulation
    of miR-126-3p, miR-202 and single-nucleotide polymorphism of miR-1269 result in
    increased LRP6 mRNA stability and protein levels. The long non-coding RNA FOX2-ASI,
    upregulated in HCC, targets and downregulates DKK1 mRNA (LRP6 inhibitor), thus
    increasing LRP6 membrane levels. (C) In breast cancers (BCs), LRP6 overexpression
    is observed in 20%–36% of carcinomas, and β-catenin nuclear accumulation is reported
    in 40%–60% of cases. (D) In pancreatic ductal adenocarcinoma (PDAC), (i) mutations
    of RNF43 are observed in 5%–10% of PDAC patients, (ii) down-regulation of miR-454
    and (iii) upregulation of LINC01133—a long non-coding RNA which induces DKK1 promoter
    methylation (decreasing DKK1 expression)—all explain increased LRP6 expression
    and subsequent increased β-catenin-dependent signaling.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - HRAS
  - BRAF
  - WNT8A
  - KRAS
  - NRAS
  - RNF43
  - WNT2B
  - WNT8B
  - WNT10B
  - WNT11
  - WNT5B
  - WNT9A
  - WNT9B
  - WNT10A
  - RAF1
  - FZD5
  - FZD3
  - FZD1
  - FZD4
  - FZD6
  - FZD7
  - FZD8
  - FZD9
  - LRP6
  - MAP2K2
  - ARAF
  - APC
  - AXIN1
  - AXIN2
  - CTNNB1
  - CSNK1A1
  - CHKA
  - WNT16
  - WNT4
  - WNT1
  - WNT2
  - MAP2K1
  - MAPK3
  - FZD10
  - FZD2
  - WNT7A
  - WNT7B
  - DVL1
  - DVL2
  - DVL3
  - DKK1
  - WNT3
  - WNT5A
  - WNT6
  - MAPK1
  - WNT3A
  - Cancer
  - Cardiomyopathy
  - Noonan syndrome
genes:
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT8A
  entrez: '7478'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: RNF43
  symbol: RNF43
  source: hgnc_symbol
  hgnc_symbol: RNF43
  entrez: '54894'
- word: WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT2B
  entrez: '7482'
- word: WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT8B
  entrez: '7479'
- word: WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT10B
  entrez: '7480'
- word: WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT11
  entrez: '7481'
- word: WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT5B
  entrez: '81029'
- word: WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT9A
  entrez: '7483'
- word: WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT9B
  entrez: '7484'
- word: WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT10A
  entrez: '80326'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: Frizzled
  symbol: Frizzled
  source: bioentities_symbol
  hgnc_symbol: FZD5
  entrez: '7855'
- word: Frizzled
  symbol: Frizzled
  source: bioentities_symbol
  hgnc_symbol: FZD3
  entrez: '7976'
- word: Frizzled
  symbol: Frizzled
  source: bioentities_symbol
  hgnc_symbol: FZD1
  entrez: '8321'
- word: Frizzled
  symbol: Frizzled
  source: bioentities_symbol
  hgnc_symbol: FZD4
  entrez: '8322'
- word: Frizzled
  symbol: Frizzled
  source: bioentities_symbol
  hgnc_symbol: FZD6
  entrez: '8323'
- word: Frizzled
  symbol: Frizzled
  source: bioentities_symbol
  hgnc_symbol: FZD7
  entrez: '8324'
- word: Frizzled
  symbol: Frizzled
  source: bioentities_symbol
  hgnc_symbol: FZD8
  entrez: '8325'
- word: Frizzled
  symbol: Frizzled
  source: bioentities_symbol
  hgnc_symbol: FZD9
  entrez: '8326'
- word: KRAS
  symbol: KRAS
  source: hgnc_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: LRP6
  symbol: LRP6
  source: hgnc_symbol
  hgnc_symbol: LRP6
  entrez: '4040'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: APC
  symbol: APC
  source: hgnc_symbol
  hgnc_symbol: APC
  entrez: '324'
- word: Axin
  symbol: AXIN
  source: bioentities_symbol
  hgnc_symbol: AXIN1
  entrez: '8312'
- word: Axin
  symbol: AXIN
  source: bioentities_symbol
  hgnc_symbol: AXIN2
  entrez: '8313'
- word: B-catenin
  symbol: beta-catenin
  source: hgnc_alias_symbol
  hgnc_symbol: CTNNB1
  entrez: '1499'
- word: BRAF
  symbol: BRAF
  source: hgnc_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: CK1
  symbol: CK1
  source: hgnc_alias_symbol
  hgnc_symbol: CSNK1A1
  entrez: '1452'
- word: CKI
  symbol: CKI
  source: hgnc_alias_symbol
  hgnc_symbol: CHKA
  entrez: '1119'
- word: WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT16
  entrez: '51384'
- word: WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT4
  entrez: '54361'
- word: WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT1
  entrez: '7471'
- word: WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT2
  entrez: '7472'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: Frizzled
  symbol: Frizzled
  source: bioentities_symbol
  hgnc_symbol: FZD10
  entrez: '11211'
- word: Frizzled
  symbol: Frizzled
  source: bioentities_symbol
  hgnc_symbol: FZD2
  entrez: '2535'
- word: WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT7A
  entrez: '7476'
- word: WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT7B
  entrez: '7477'
- word: Dvl
  symbol: DVL
  source: bioentities_symbol
  hgnc_symbol: DVL1
  entrez: '1855'
- word: Dvl
  symbol: DVL
  source: bioentities_symbol
  hgnc_symbol: DVL2
  entrez: '1856'
- word: Dvl
  symbol: DVL
  source: bioentities_symbol
  hgnc_symbol: DVL3
  entrez: '1857'
- word: DKK1)
  symbol: DKK1
  source: hgnc_symbol
  hgnc_symbol: DKK1
  entrez: '22943'
- word: WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT3
  entrez: '7473'
- word: WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT5A
  entrez: '7474'
- word: WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT6
  entrez: '7475'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT3A
  entrez: '89780'
chemicals: []
diseases:
- word: Cancer
  source: ''
  identifier: ''
- word: Cardiomyopathy
  source: ''
  identifier: ''
- word: Noonan syndrome
  source: ''
  identifier: ''
---
